Matthew Rossiter represents startup companies, established public companies and venture capital investors, with particular focus on the life science and broader technology-enabled healthcare industries. He advises clients on a variety of corporate and intellectual property transactions, including the formation of startup ventures, equity and debt financings, mergers and acquisitions, and complex commercial and intellectual property transactions.
Matt seeks to provide clients with practical, thoughtful advice to help solve their business and legal issues, and assists clients in structuring, negotiating and closing business transactions quickly and effectively. His practice also includes providing day‐to‐day counseling to companies and boards of directors on a wide range of other corporate matters.
Matt is the lead researcher and co‐author of Fenwick & West’s Life Sciences Financing Survey, a biannual report that analyzes the valuations and terms of venture financings for the U.S. life science companies, as well as trends in life science financing, VC fundraising, M&A and IPO activity.
In addition, Matt served as an interim in-house legal counsel for Virgin America during the startup phase of its operations. Matt is a frequent lecturer at Stanford Law School and Wharton Business School.
While in school, Matt was a member of the Duke Law Journal and was named recipient of the Faculty Award in Business Organization and Finance.